Living-Donor Lobar Lung Transplantation for Pulmonary Arterial Hypertension After Failure of Epoprostenol Therapy
- 7 August 2007
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 50 (6), 523-527
- https://doi.org/10.1016/j.jacc.2007.03.054
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Registry of the International Society for Heart and Lung Transplantation: Twenty-second Official Adult Lung and Heart-Lung Transplant Report—2005The Journal of Heart and Lung Transplantation, 2005
- Improved survival after living-donor lobar lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Outcomes in Children With Idiopathic Pulmonary Arterial HypertensionCirculation, 2004
- Clinical classification of pulmonary hypertensionJournal of the American College of Cardiology, 2004
- A decade of living lobar lung transplantation: recipient outcomesThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Living-donor lobar lung transplantation for various lung diseasesThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Outcome in 91 Consecutive Patients with Pulmonary Arterial Hypertension Receiving EpoprostenolAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survivalJournal of the American College of Cardiology, 2002
- Primary Pulmonary HypertensionAnnals of Internal Medicine, 1987